Mary Poupot

Title: Mary Poupot: Innovator in Cancer Research

Introduction

Mary Poupot is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of cancer research, particularly in the development of innovative therapeutic approaches targeting tumor-associated macrophages.

Latest Patents

Mary Poupot holds 2 patents that showcase her groundbreaking work. One of her latest patents is focused on antibodies targeting tumor-associated macrophages (TAMs). This invention relates to the identification of specific markers on the surface of macrophages associated with tumors, allowing for the detection and targeting of TAMs. The research demonstrated that sideroflexin 3, which is absent in normal macrophages, is expressed by tumor-associated macrophages. By using antibodies directed at sideroflexin 3, the inventors were able to deplete TAMs in PBMC samples obtained from leukemia patients, significantly reducing the number of leukemic B cells. Another notable patent involves phosphorylated dendrimers as anti-inflammatory drugs, which are dendrimers with monophosphonic or bisphosphonic terminations designed for the treatment of inflammatory diseases.

Career Highlights

Throughout her career, Mary Poupot has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work has been pivotal in advancing the understanding of macrophage biology in the context of cancer.

Collaborations

Mary has collaborated with notable colleagues, including Jean-Jacques Fournie and Loïc Ysebaert, contributing to a rich exchange of ideas and research findings in her field.

Conclusion

Mary Poupot's innovative work in cancer research and her patents reflect her dedication to advancing medical science. Her contributions are paving the way for new therapeutic strategies in the fight against cancer.